Angiogenesis and leukemia.

[1]  P. Venugopal,et al.  Improvement in cytopenias of patients with myelodysplastic syndromes (Mds) In response to thalidomide , 2000 .

[2]  E. Estey,et al.  Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. , 1999, Blood.

[3]  S. Rafii,et al.  Regulation of Transendothelial Migration of Hematopoietic Progenitor Cells , 1999, Annals of the New York Academy of Sciences.

[4]  T. Grogan,et al.  Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. , 1999, Cancer research.

[5]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  M. Ratajczak,et al.  Role of vascular endothelial growth factor (VEGF) and placenta‐derived growth factor (PlGF) in regulating human haemopoietic cell growth , 1998, British journal of haematology.

[7]  U. Dirnagl,et al.  Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons , 1998, Neuroscience Letters.

[8]  Shay Soker,et al.  Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.

[9]  S. Rafii,et al.  Regulation of hematopoiesis by microvascular endothelium. , 1997, Leukemia & lymphoma.

[10]  H. Stein,et al.  Expression of vascular endothelial growth factor in lymphomas and castleman's disease , 1997, The Journal of pathology.

[11]  S. Ergün,et al.  Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia , 1997, Leukemia.

[12]  A. Harris,et al.  Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Ergün,et al.  Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. , 1997, Blood.

[14]  G. Neufeld,et al.  VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix* , 1997, The Journal of Biological Chemistry.

[15]  S. Sallan,et al.  Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. , 1997, The American journal of pathology.

[16]  V. Hombach,et al.  Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. , 1996, Circulation.

[17]  R. Kendall,et al.  Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. , 1996, Biochemical and biophysical research communications.

[18]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[19]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[20]  Hung V. Nguyen,et al.  The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.

[21]  K. Alitalo,et al.  A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases. , 1996, The EMBO journal.

[22]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[23]  D. Mukhopadhyay,et al.  Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. , 1995, Cancer research.

[24]  D. Ribatti,et al.  Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. , 1995, Leukemia & lymphoma.

[25]  R. Kerbel,et al.  Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. , 1995, Cancer research.

[26]  S. Kourembanas,et al.  Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. , 1995, Circulation research.

[27]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[28]  M. Goldberg,et al.  Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*) , 1995, The Journal of Biological Chemistry.

[29]  B. Spiegelman,et al.  Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. , 1995, Biochimica et biophysica acta.

[30]  L. Ellis,et al.  The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.

[31]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[32]  D. Ribatti,et al.  Bone marrow angiogenesis and progression in multiple myeloma , 1994, British journal of haematology.

[33]  S. Rafii,et al.  Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion , 1994 .

[34]  A. Ullrich,et al.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.

[35]  J. Park,et al.  The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. , 1993, Molecular biology of the cell.

[36]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[37]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[38]  H. Moukadiri,et al.  Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. , 1990, The Journal of biological chemistry.

[39]  D. Gospodarowicz,et al.  Characterization of the receptors for vascular endothelial growth factor. , 1990, The Journal of biological chemistry.

[40]  M. Maragoudakis,et al.  Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system. , 1989, The Journal of pharmacology and experimental therapeutics.

[41]  J. Folkman.  Successful treatment of an angiogenic disease. , 1989, The New England journal of medicine.

[42]  Peter J. Polverini,et al.  Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene , 1989, Cell.

[43]  D. Ingber,et al.  Inhibition of angiogenesis through modulation of collagen metabolism. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[44]  J. Folkman.  What is the role of angiogenesis in metastasis from cutaneous melanoma? , 1987, European journal of cancer & clinical oncology.

[45]  D. Ingber,et al.  A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. , 1986, Endocrinology.

[46]  J. Folkman,et al.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.

[47]  B. Zetter,et al.  Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells. , 1981, The New England journal of medicine.

[48]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[49]  G. Rodgers,et al.  Evidence of increased angiogenesis in patients with acute myeloid leukemia. , 2000, Blood.

[50]  W. Hunter,et al.  The antineoplastic ether lipid, s-phosphonate, selectively induces apoptosis in human leukemic cells and exhibits antiangiogenic and apoptotic activity on the chorioallantoic membrane of the chick embryo , 1998, Cancer Chemotherapy and Pharmacology.

[51]  D. Ribatti,et al.  Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis , 1998, International journal of clinical & laboratory research.

[52]  E. Kohn,et al.  The biochemistry of cancer dissemination. , 1997, Critical reviews in biochemistry and molecular biology.